logo
Plus   Neg
Share
Email

Rio Tinto Considers Options After Takeovers Panel Ruling On ERA

Rio Tinto plc (RTPPF.PK,RIO.L,RIO,RTNTF.PK) is considering its options after the Takeovers Panel ruled that Rio Tinto can't use its funding of a clean up of a NT uranium mine to buy a partially owned subsidiary.

Rio Tinto said it acknowledges the findings of the Takeovers Panel in relation to Energy Resources of Australia Limited's (ERA) renounceable entitlement offer to raise $324 million or A$476 million for the rehabilitation of the Ranger Project Area in Australia's Northern Territory.

"While the Panel has made a declaration of unacceptable circumstances and has made orders, the Panel has allowed the Entitlement Offer to proceed," Energy Resources of Australia said.

"ERA rejects any suggestion that potential conflicts of interest have not been sufficiently managed at any time during the process of developing a funding solution. However, ERA does not intend to seek a review of the Panel's decision on the basis that the Entitlement Offer is proceeding," ERA said.

Rio Tinto group executive Energy & Minerals Bold Baatar said "We will now consider our options in light of the Panel's orders so that ERA can fulfil its important rehabilitation obligations and commitments to the communities in which it operates and relevant authorities."

Under the terms of its mining approvals, ERA is required to end mining and processing activities at Ranger by January 2021 and complete final rehabilitation by January 2026.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apple Inc. (AAPL) Wednesday reported a first-quarter profit that trumped Wall Street estimates, as the iPhone maker reported its "highest quarterly revenue ever" driven by strong demand for its iPhone 11 and 11 Pro models during the holiday season. The tech giant also issued a strong revenue outlook... New York Attorney General Letitia James has fled a lawsuit against Vyera Pharmaceuticals and two of its former CEOs, including imprisoned 'Pharma Bro' Martin Shkreli, for illegally monopolizing a life-saving drug Daraprim. The lawsuit seeks a lifetime ban on Shkreli and his business partner Kevin Mulleady working in the pharmaceutical industry. Graco Inc. (GGG) shares were climbing more than 7 percent in morning trade. Monday after market close, the company had reported a surge in the fourth-quarter earnings to $84.8 million from $73.7 million in the prior year. Earnings per share surpassed analysts' estimates. Sales were up 1 percent to $412.3...
Follow RTT
>